Sentence examples for assay utility from inspiring English sources

The outcomes from these two proficiency panels first provide Initial Elispot Harmonization Guidelines for Optimizing Assay Performance (Fig.  1) that can fulfill this need and may provide if implemented widely the grounds for substantial improvement of assay utility for research applications and development of immune therapies.

Antigen selection from a wide range of potential targets., Antigenic polymorphism.,, Apparent need for extremely high antibody titers for anti-merozoite antigen vaccines to achieve protection.,, Lack of consensus regarding mechanisms of blood-stage immunity and strategies for vaccine design (e.g., antibody- vs. T cell-inducing), coupled with uncertainty of in vitro assay utility.

However, like with any blotting assay, the utility is limited by its technical complexity (i.e. immunoprecipitation followed by immunoblotting) and the results with this assay are only semi-quantitative.

However, there have not been independent assessments of candidate assays, or consensus metrics of an assay's utility for incidence estimation.

Issues of DNA contamination, required technical expertise, and PCR costs prohibit this assay's utility as a routine clinical diagnostic tool in the field (3, 5, 13, 14 ).

Although both blood and BAL fluid are regularly tested by PCR assays, their utility differs considerably.

The aim of this work was to determine which other assays have utility for inclusion.

The modeling outputs could also be used to rank in vitro assays for utility in predicting toxicity and to suggest optimal chemical concentration ranges for future qHTS experiments.

These assays offer utility in assisting with diagnosis of SFD in both wild and captive snakes in addition to providing an important research tool for better understanding the biology of the fungus and ecology of this disease.

Both the VeraTag™ lysate and FFPE cell assays demonstrated utility in the study of drug action and in the evaluation of activated HER1/HER2 forms in HER2-positive breast tumor tissue.

Our results are similar to those reported by mammalian cell reporter gene assays, confirming the utility of our assay in identifying TR subtype-selective therapeutics.